Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

主页 知识 Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

Safety concerns regarding coccidiosis vaccines. Comparison of attenuated and non-attenuated vaccines

The aim of this study was to compare the safety parameters of commercial non-attenuated and attenuated (Jeffers, 1975) Eimeria vaccines with EVALON®, a live attenuated coccidiosis vaccine for breeders and layers. 525 chickens were vaccinated orally at 1 day of age with either PBS (group 1), an attenuated vaccine (groups 2 and 4), including EVALON® (HIPRA) (group 2), or non-attenuated vaccines (groups 3 and 5).

关于该文章

出现于

WVPA Congress, 2017

日期

2017年9月28日

作者

Dardi, M.; Baratelli, M.; Boix, O.; Pagès, M.

摘要

The outcomes of this trial suggest that both attenuation and also its grade might be important factors to take into account when selecting live coccidiosis vaccines. This study also supports the safety of EVALON®, a live attenuated vaccine designed to confer protection without compromising the health status of vaccinated animals.

相关产品

共享

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}